Pharmaceutical compositions containing 2 - 6 - (3 - amino - pipenidin - 1 - il) - 3 - methyl - 2 - - 3,4-dihydro - 2H - primidin IL - 1 - methyl - 4 - fluoro Benzonitrile. Use. Method of treatment, Weekly Administration of inhibitors of dipeptidilpeptidasa.

摘要

The pharmaceutical ingredients provided include 2 - [6 - (3-amino-pyridine-1-il) - 3-methyl-2,4-diazo-3,4-dihydro-2h-pyridine-1-methyl] - 4-fluorobenzoate and its pharmaceutically acceptable salts, as well as kits and manufactured products including pharmaceutical ingredients, There are also ways to use pharmaceutical ingredients. First item: a method, which is characterized in that it includes the injection of a weekly dose of compound 1 to patients with a dose of more than 250 mg per week. Requirement No. 14: a pharmaceutical ingredient manufactured in an individual dose,The characteristic is that it contains more than 250 mg of compound 1. Requirement No. 26: use compound 1 to make a pharmaceutical ingredient in accordance with any 14-25 requirements. Requirement No. 27: diabetes treatment method, which is characterized by providing a patient with more than 250 mgdel level 1 dose once a week, once a week. Stage 28: cancer treatmentIt is characterized by a weekly dose of more than 250 mg to endocrine patients, once a week. Item 29: a method of treatment of autoimmune disorder, characterized in that it includes administration of more than 250 mg once a week to patients from compound 1. Requirement 30: a treatment for HIV infection characterized by weekly injection of more than 250 mg of compound 1 to patients once a week.